Similar articles

• Hydroxychloroquine Dose and Risk of Systemic Lupus Erythematosus Flares.

  Caravaca-Fontán F, Yandian F, Fervenza FC. Caravaca-Fontán F, et al. JAMA. 2023 Feb 28;329(8):685-686. doi: 10.1001/jama.2022.23159. JAMA. 2023. PMID: 36853254 No abstract available.
• Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.

  Jorge AM, Mancini C, Zhou B, Ho G, Zhang Y, Costenbader K, Choi HK. Jorge AM, et al. JAMA. 2022 Oct 11;328(14):1458-1460. doi: 10.1001/jama.2022.13591. JAMA. 2022. PMID: 36112387 Free PMC article.
• A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.

  Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senécal JL, Cividino A, Danoff D, Osterland CK, Yeadon C, Smith CD. Tsakonas E, et al. Lupus. 1998;7(2):80-5. doi: 10.1191/096120398678919778. Lupus. 1998. PMID: 9541091 Clinical Trial.
• Interventions for cutaneous disease in systemic lupus erythematosus.

  Hannon CW, McCourt C, Lima HC, Chen S, Bennett C. Hannon CW, et al. Cochrane Database Syst Rev. 2021 Mar 9;3(3):CD007478. doi: 10.1002/14651858.CD007478.pub2. Cochrane Database Syst Rev. 2021. PMID: 33687069 Free PMC article.
• Hydroxychloroquine in systemic lupus erythematosus (SLE).

  Ponticelli C, Moroni G. Ponticelli C, et al. Expert Opin Drug Saf. 2017 Mar;16(3):411-419. doi: 10.1080/14740338.2017.1269168. Epub 2016 Dec 14. Expert Opin Drug Saf. 2017. PMID: 27927040 Review.